Proteasome inhibition: mechanism of action
- PMID: 19791423
Proteasome inhibition: mechanism of action
Abstract
The ubiquitin-proteasome pathway plays a significant role in neoplastic growth and metastasis. The proteasome is responsible for most intracellular protein degradation and regulates numerous cellular functions. Aberrations in cell cycle control caused by altered levels of specific cell-cycle related proteins may lead to oncogenesis. Dysregulation of NF-kappaB signaling also is common to many malignancies and is one of the critical pathways affected by proteasome inhibition. The proteasome structure, in the context of the ubiquitin-proteasome pathway, is discussed. Proteasome inhibitors, such as bortezomib, have the potential to target specific protein substrates, leading to decreased tumor cell growth and increased apoptosis.
Similar articles
-
Proteasome inhibition as a novel therapeutic target in human cancer.J Clin Oncol. 2005 Jan 20;23(3):630-9. doi: 10.1200/JCO.2005.11.030. J Clin Oncol. 2005. PMID: 15659509 Review.
-
Proteasome inhibition as a therapeutic strategy for hematologic malignancies.Expert Rev Anticancer Ther. 2005 Jun;5(3):465-76. doi: 10.1586/14737140.5.3.465. Expert Rev Anticancer Ther. 2005. PMID: 16001954 Review.
-
Proteasome inhibitors as therapeutics.Essays Biochem. 2005;41:205-18. doi: 10.1042/EB0410205. Essays Biochem. 2005. PMID: 16250907 Review.
-
Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.Cancer Res. 2007 Oct 15;67(20):10078-86. doi: 10.1158/0008-5472.CAN-06-3982. Cancer Res. 2007. PMID: 17942942
-
The role of proteasome in malignant diseases.J BUON. 2007 Sep;12 Suppl 1:S95-9. J BUON. 2007. PMID: 17935285 Review.
Cited by
-
Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways.Cancers (Basel). 2023 Apr 26;15(9):2468. doi: 10.3390/cancers15092468. Cancers (Basel). 2023. PMID: 37173935 Free PMC article.
-
Association with proteasome determines pathogenic threshold of polyglutamine expansion diseases.Biochem Biophys Res Commun. 2021 Jan 15;536:95-99. doi: 10.1016/j.bbrc.2020.12.065. Epub 2020 Dec 25. Biochem Biophys Res Commun. 2021. PMID: 33370719 Free PMC article.